---
title: Safety of Local Dental Anesthesia in Patients With Cardiac Channelopathies
nct_id: NCT03182777
overall_status: COMPLETED
phase: NA
sponsor: University of Sao Paulo General Hospital
study_type: INTERVENTIONAL
primary_condition: Channelopathies
countries: Brazil
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT03182777.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT03182777"
ct_last_update_post_date: 2024-04-09
last_seen_at: "2026-05-12T06:27:58.685Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Safety of Local Dental Anesthesia in Patients With Cardiac Channelopathies

**NCT ID:** [NCT03182777](https://clinicaltrials.gov/study/NCT03182777)

## Key Facts

- **Status:** COMPLETED
- **Phase:** NA
- **Study Type:** INTERVENTIONAL
- **Target Enrollment:** 31
- **Lead Sponsor:** University of Sao Paulo General Hospital
- **Collaborators:** Fundação de Amparo à Pesquisa do Estado de São Paulo
- **Conditions:** Channelopathies, Brugada Syndrome, Long QT Syndrome, Ventricular, Tachycardia
- **Start Date:** 2015-05
- **Completion Date:** 2018-08
- **CT.gov Last Update:** 2024-04-09

## Brief Summary

Patients with cardiac channelopathies needing restorative dental treatment will be included in two sessions of the study, using local dental anesthetic: lidocaine 2% with epinephrine and lidocaine 2% without vasoconstrictor. The safety of the use of two cartridges (3.6 mL) will be evaluated. The patients will be their own control and will be assessed by Holter monitoring for 28 hours, blood pressure measurement and anxiety measuring.

## Detailed Description

Patients of Heart Institute of the University of São Paulo with inherited cardiac channelopathies will be included, considering the criteria for inclusion and non-inclusion, after reading and signing the informed consent.

They will undergo dental restorative treatment in two sessions, in the morning period, with an interval of at least seven days (wash-out) between them, and the patients will be their own control.

In the first session, after randomization, patients will receive lidocaine 2% without vasoconstrictor (LSA) or lidocaine 2% with 1: 100,000 epinephrine (LCA) (cross-over), resulting in two conditions: with adrenaline and without adrenaline.

The randomization of the anesthetic solution will be performed by the main researcher, being blind to the performer researcher and to the patient.

The injected volume will be 3.6 mL (2 cartridges) of the anesthetic solution, using blocking technique of the inferior alveolar nerve.

The patients will be monitored by Holter for 28 hours starting one hour before the procedure, for registration and analysis of cardiac electrical activity during the two sessions. Blood pressure will be monitored with digital sphygmomanometer and anxiety will be measured with Facial Image Scale, both on three occasions: at the beginning of the baseline periods, before starting application of anesthesia and at the end of the proceedings. The results will be analyzed statistically.

## Eligibility

- **Minimum age:** 6 Years
- **Sex:** ALL
- **Healthy Volunteers:** No

```
Inclusion Criteria:

* Patients with any channelopathies below, kept on optimal drug therapy, with or without ICD:

Brugada Syndrome, Long QT Syndrome and Catecholaminergic Polymorphic Ventricular Tachycardia

* Dental caries or unsatisfactory restorations in the mandible, indicating restorative dental treatment

Exclusion Criteria:

* Patients allergic to lidocaine
* Patients undergoing ICD therapy for less than three months
* Patients with recurrent syncope in the last three months
* Patients with sustained arrhythmias documented for less than 3 months
* Have received epinephrine in the last 24 hours
```

## Arms

- **Lidocaine with epinephrine** (ACTIVE_COMPARATOR) — Application of local dental anesthesia with two cartridges (3,6 mL) of lidocaine 2% with epinephrine 1:100.000 for dental restorative procedures in patients with cardiac channelopathies.
- **Lidocaine** (ACTIVE_COMPARATOR) — Application of local dental anesthesia with two cartridges (3,6 mL) of lidocaine 2% without vasoconstrictor for dental restorative procedures in patients with cardiac channelopathies.

## Interventions

- **Dental restorative procedure** (PROCEDURE) — Infiltration of two cartridges (3.6 mL) of local anesthetics with 2% lidocaine with or without epinephrine 1:100,000, in two sessions with an interval of seven days between them, in oral mucosa in patients with cardiac channelopathies.

## Primary Outcomes

- **No sustained ventricular tachycardia** _(time frame: during dental procedures)_ — No life-threatening arrhythmias and clinical signs and symptoms

## Locations (1)

- Heart Institute of Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.phases` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `sponsor.collaborators` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.heart institute of hospital das clínicas da faculdade de medicina da universidade de são paulo|são paulo||brazil` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT03182777.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT03182777*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*